ArticleLeukemia2003
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
A M Martelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this papercites it